But much is yet to be learned about this complex disorder
The toxin resembled glucagon, a hormone that raises blood sugar, so, scientists named it glucagon-like-peptide 1, or GLP-1. In the early 2000s, we got our first medical breakthrough with GLP-1, a drug called exenatide (Byetta) approved for the treatment of type 2 diabetes
Opioid-Related Pathways Animal work suggests that some DSIP effects may involve endogenous opioid signalling
Bisher gibt es jedoch keine Hinweise auf ein solches Risiko.
Prolotherapy has been shown to reduce pain and stiffness, and improve knee function and quality of life in knee OA patients
Diabetes 49, 424430 (2000)